RSV Unveiled: Breaking Down the New Vaccines on the Block
QPD Podcast by Cambiar Investors
S3 · E2
May 16, 2024
16:10
Episode notes
In this episode of the QPD Podcast, Dr. Raymond Blum, a board-certified expert in internal medicine and infectious diseases, discusses the impact of respiratory syncytial virus (RSV).
We explore the revolutionary new vaccines, their development, effectiveness, and impact on public health.
Keywords
RSV
healthcare
vaccines
GSK
Arexvy
international stocks